blue cross blue shield not covering glp 1 Excellus clarifies GLP-1 coverage ahead of 2026 formulary changes Excellus BCBS will stop paying

Glycemic Safety Of particular importance given the glucagon receptor agonism component of retatrutide, there were no clinically significant increases in blood glucose or concerning hyperglycemic events despite glucagon's classical glucose-raising effects - confirming that the GLP-1 component successfully counteracts glucagon's impact on glucose homeostasis

This 3.5-point increase corresponds with the broader integration of GLP-1 therapies into structured medical nutrition protocols

Diabetes Metab J (2020) 44(1):1132

How Excellus BlueCross BlueShield (BCBS) helps employers manage this trend As the GLP-1 landscape evolves, we are dedicated to keeping our policies aligned with the latest data to ensure the best outcomes for your team

Fralick, M., Colacci, M., Odutayo, A., Siemieniuk, R., & Glynn, R

Nooms accessibly priced Microdose GLP-1 Rx Program, starting at $99, builds on the companys advocacy efforts on behalf of patients in the US